Cargando…

The effects of S-nitrosylation-induced PPARγ/SFRP5 pathway inhibition on the conversion of non-alcoholic fatty liver to non-alcoholic steatohepatitis

BACKGROUND: Peroxisome proliferators-activated receptors γ (PPARγ) and secreted frizzled related protein 5 (SFRP5) are abnormally expressed in liver cells. But their role in the transformation of non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH) remains to be studied. We aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hongyun, Li, Fengxia, Feng, Jing, Wang, Junping, Liu, Xiaobing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106108/
https://www.ncbi.nlm.nih.gov/pubmed/33987382
http://dx.doi.org/10.21037/atm-21-1070
_version_ 1783689718129491968
author Wang, Hongyun
Li, Fengxia
Feng, Jing
Wang, Junping
Liu, Xiaobing
author_facet Wang, Hongyun
Li, Fengxia
Feng, Jing
Wang, Junping
Liu, Xiaobing
author_sort Wang, Hongyun
collection PubMed
description BACKGROUND: Peroxisome proliferators-activated receptors γ (PPARγ) and secreted frizzled related protein 5 (SFRP5) are abnormally expressed in liver cells. But their role in the transformation of non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH) remains to be studied. We aimed to explore the role of S-nitrosylation (SNO) in the conversion of NAFL to NASH via the peroxisome PPARγ/SFRP5 pathway. METHODS: A normal diet and methionine-choline deficient diet were used to construct the NAFL and NASH mouse models, respectively. The differences between the SNO of PPARγ in both models were measured by irreversible biotinylation. Quantitative reverse transcription PCR (qRT-PCR) and Western blotting were used to detect the effect of SNO on the expression of PPARγ messageRNA (mRNA) and protein in L02 hepatocytes. Nubiscan software, luciferase reporter gene, and chromatin immunoprecipitation assay (CHIP) were used to verify the targeting relationship between PPAR and SFRP5. The expression of tumor necrosis factor α (TNFα), interleukin-1β (IL-1β), and interleukin-6 (IL-6), which are indicators for the activation of Kupffer cells, were determined by enzyme linked immunosorbent assay (ELISA) after co-cultivation of L02 hepatocytes and Kupffer macrophages, as well as the exogenous regulation of SNO, PPARγ, and SFRP5 in hepatic L02 cells. RESULTS: The NAFL and NASH mouse models were successfully constructed, and the level of PPARγ SNO in the NAFL model was significantly lower than the NASH model (P<0.05). The level of PPARγ was significantly downregulated after increasing the SNO of L02 cells, respectively (P<0.05). Nubiscan software and CHIP confirmed that PPARγ could bind to the promoter region of SFRP5 (P<0.05). Overexpression of PPARγ and SFRP5 could significantly downregulate the expression of TNFα, IL-1β, and IL-6 (P<0.05) correspondingly, while increasing the SNO level of L02 cells could restore the expression levels of TNFα, IL-1β, and IL-6. CONCLUSIONS: SNO promoted the activation of macrophage Kupffer cells by inhibiting the PPARγ/SFRP5 pathway in L02 hepatocytes, thereby promoting the conversion of NAFL into NASH.
format Online
Article
Text
id pubmed-8106108
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-81061082021-05-12 The effects of S-nitrosylation-induced PPARγ/SFRP5 pathway inhibition on the conversion of non-alcoholic fatty liver to non-alcoholic steatohepatitis Wang, Hongyun Li, Fengxia Feng, Jing Wang, Junping Liu, Xiaobing Ann Transl Med Original Article BACKGROUND: Peroxisome proliferators-activated receptors γ (PPARγ) and secreted frizzled related protein 5 (SFRP5) are abnormally expressed in liver cells. But their role in the transformation of non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH) remains to be studied. We aimed to explore the role of S-nitrosylation (SNO) in the conversion of NAFL to NASH via the peroxisome PPARγ/SFRP5 pathway. METHODS: A normal diet and methionine-choline deficient diet were used to construct the NAFL and NASH mouse models, respectively. The differences between the SNO of PPARγ in both models were measured by irreversible biotinylation. Quantitative reverse transcription PCR (qRT-PCR) and Western blotting were used to detect the effect of SNO on the expression of PPARγ messageRNA (mRNA) and protein in L02 hepatocytes. Nubiscan software, luciferase reporter gene, and chromatin immunoprecipitation assay (CHIP) were used to verify the targeting relationship between PPAR and SFRP5. The expression of tumor necrosis factor α (TNFα), interleukin-1β (IL-1β), and interleukin-6 (IL-6), which are indicators for the activation of Kupffer cells, were determined by enzyme linked immunosorbent assay (ELISA) after co-cultivation of L02 hepatocytes and Kupffer macrophages, as well as the exogenous regulation of SNO, PPARγ, and SFRP5 in hepatic L02 cells. RESULTS: The NAFL and NASH mouse models were successfully constructed, and the level of PPARγ SNO in the NAFL model was significantly lower than the NASH model (P<0.05). The level of PPARγ was significantly downregulated after increasing the SNO of L02 cells, respectively (P<0.05). Nubiscan software and CHIP confirmed that PPARγ could bind to the promoter region of SFRP5 (P<0.05). Overexpression of PPARγ and SFRP5 could significantly downregulate the expression of TNFα, IL-1β, and IL-6 (P<0.05) correspondingly, while increasing the SNO level of L02 cells could restore the expression levels of TNFα, IL-1β, and IL-6. CONCLUSIONS: SNO promoted the activation of macrophage Kupffer cells by inhibiting the PPARγ/SFRP5 pathway in L02 hepatocytes, thereby promoting the conversion of NAFL into NASH. AME Publishing Company 2021-04 /pmc/articles/PMC8106108/ /pubmed/33987382 http://dx.doi.org/10.21037/atm-21-1070 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Wang, Hongyun
Li, Fengxia
Feng, Jing
Wang, Junping
Liu, Xiaobing
The effects of S-nitrosylation-induced PPARγ/SFRP5 pathway inhibition on the conversion of non-alcoholic fatty liver to non-alcoholic steatohepatitis
title The effects of S-nitrosylation-induced PPARγ/SFRP5 pathway inhibition on the conversion of non-alcoholic fatty liver to non-alcoholic steatohepatitis
title_full The effects of S-nitrosylation-induced PPARγ/SFRP5 pathway inhibition on the conversion of non-alcoholic fatty liver to non-alcoholic steatohepatitis
title_fullStr The effects of S-nitrosylation-induced PPARγ/SFRP5 pathway inhibition on the conversion of non-alcoholic fatty liver to non-alcoholic steatohepatitis
title_full_unstemmed The effects of S-nitrosylation-induced PPARγ/SFRP5 pathway inhibition on the conversion of non-alcoholic fatty liver to non-alcoholic steatohepatitis
title_short The effects of S-nitrosylation-induced PPARγ/SFRP5 pathway inhibition on the conversion of non-alcoholic fatty liver to non-alcoholic steatohepatitis
title_sort effects of s-nitrosylation-induced pparγ/sfrp5 pathway inhibition on the conversion of non-alcoholic fatty liver to non-alcoholic steatohepatitis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8106108/
https://www.ncbi.nlm.nih.gov/pubmed/33987382
http://dx.doi.org/10.21037/atm-21-1070
work_keys_str_mv AT wanghongyun theeffectsofsnitrosylationinducedppargsfrp5pathwayinhibitionontheconversionofnonalcoholicfattylivertononalcoholicsteatohepatitis
AT lifengxia theeffectsofsnitrosylationinducedppargsfrp5pathwayinhibitionontheconversionofnonalcoholicfattylivertononalcoholicsteatohepatitis
AT fengjing theeffectsofsnitrosylationinducedppargsfrp5pathwayinhibitionontheconversionofnonalcoholicfattylivertononalcoholicsteatohepatitis
AT wangjunping theeffectsofsnitrosylationinducedppargsfrp5pathwayinhibitionontheconversionofnonalcoholicfattylivertononalcoholicsteatohepatitis
AT liuxiaobing theeffectsofsnitrosylationinducedppargsfrp5pathwayinhibitionontheconversionofnonalcoholicfattylivertononalcoholicsteatohepatitis
AT wanghongyun effectsofsnitrosylationinducedppargsfrp5pathwayinhibitionontheconversionofnonalcoholicfattylivertononalcoholicsteatohepatitis
AT lifengxia effectsofsnitrosylationinducedppargsfrp5pathwayinhibitionontheconversionofnonalcoholicfattylivertononalcoholicsteatohepatitis
AT fengjing effectsofsnitrosylationinducedppargsfrp5pathwayinhibitionontheconversionofnonalcoholicfattylivertononalcoholicsteatohepatitis
AT wangjunping effectsofsnitrosylationinducedppargsfrp5pathwayinhibitionontheconversionofnonalcoholicfattylivertononalcoholicsteatohepatitis
AT liuxiaobing effectsofsnitrosylationinducedppargsfrp5pathwayinhibitionontheconversionofnonalcoholicfattylivertononalcoholicsteatohepatitis